Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs FCUV✓SelectedUSD · FCUVGSK vs FCUV performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs FCUV

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+43.0%
FCUV return
-99.8%
Excess return
+142.8%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioFCUVExcessAlpha
1D-2.3%-3.0%+0.6%-2.3%
7D-3.0%+56.3%-59.3%-3.0%
30D+0.4%+29.4%-29.0%+0.4%
3M-1.2%-29.4%+28.2%-1.1%
6M+0.9%+35.8%-34.9%+1.2%
YTD+4.0%-85.9%+89.9%+4.3%
1Y+7.3%-95.7%+103.0%+7.7%
3Y+57.1%-99.3%+156.4%+59.4%
5Y+43.0%-99.8%+142.8%+48.9%
All+43.0%-99.8%+142.8%+48.9%

Cumulative growth

Daily Returns

Daily percentage return beside FCUV.

Daily Out/Under-Performance

Portfolio return minus FCUV return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × FCUV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded FCUV wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling